Related Experiment Videos
Morbidity and mortality after thoracoscopic pneumonoplasty
1Department of Anesthesiology, Chapman Medical Center, Orange, California 92669, USA.
The Annals of Thoracic Surgery
|July 1, 1996
Summary
Video-assisted thoracic surgery laser pneumonoplasty can reduce lung volume in emphysema patients. However, advanced age, male sex, and poor lung function increase risks, necessitating careful patient selection for this emphysema treatment.
Area of Science:
- Pulmonary Medicine
- Thoracic Surgery
- Cardiothoracic Surgery
Background:
- Video-assisted thoracic surgery (VATS) and open pneumonoplasty are established lung reduction techniques for emphysema.
- Emphysema management often involves surgical interventions to improve lung function and quality of life.
Purpose of the Study:
- To analyze the surgical and hospital outcomes of video-assisted thoracic surgical laser pneumonoplasty.
- To identify patient factors associated with increased morbidity and mortality after lung reduction surgery.
Main Methods:
- Retrospective analysis of 339 emphysema patients undergoing VATS laser pneumonoplasty.
- Evaluation of patient demographics, pulmonary function tests (PFTs), and surgical outcomes.
Main Results:
- The study reported a 0.9% incidence of myocardial infarctions.
- The hospital mortality rate was 4.1%.
Conclusions:
- Factors associated with increased morbidity and mortality include advanced age (>65 years), male sex, and elevated resting arterial carbon dioxide tension (>55 mm Hg).
- Pre-existing poor lung function, indicated by low forced expiratory volume in 1 second (FEV1) (<700 mL for men, <500 mL for women), reduced maximum voluntary ventilation (<25% predicted), and a high residual volume/total lung capacity ratio (>60%), are critical risk factors.